UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
99
UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PPG, MFGP, REPH, REVG and PCG

NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

PPG Industries, Inc. (NYSE: PPG ) Lead Plaintiff Deadline: July 19, 2018 Class Period: April 24, 2017 - May 10, 2018

Allegations: PPG’s consolidated financial statements for the year ended December 31, 2017 and quarterly financial statements for 2017 contained improper accounting entries and could not be relied upon; PPG failed to maintain adequate internal controls; and as a result, defendants’ public statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/ppg-indu...c-2?wire=3 .

Micro Focus International plc (NYSE: MFGP ) Lead Plaintiff Deadline: July 23, 2018 Class Period: September 1, 2017 – March 19, 2018, and August 4, 2017 or August 22, 2017

Allegations: The Registration Statement and Prospectus filed for the Company’s Initial Public Offering contained materially false and misleading information and/or failed to disclose material information, and Micro Focus made materially false and misleading statements and/or failed to disclose material information throughout the class period.

Get additional information: http://www.kleinstocklaw.com/pslra-c/micro-fo...plc?wire=3 .

Recro Pharma, Inc. (NASDAQ: REPH ) Lead Plaintiff Deadline: July 30, 2018 Class Period: July 31, 2017 - May 23, 2018

Allegations: the Company's lead product, IV meloxicam, lacked supporting clinical data to show sufficient clinical benefits to receive U.S. Food and Drug Administration ("FDA") approval; and as a result, Recro Pharma's public statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/recro-ph...c-2?wire=3 .

REV Group, Inc. (NYSE: REVG ) Lead Plaintiff Deadline: August 7, 2018       Class Period: (1) pursuant to the initial public offering on or around January 27, 2017 and/or (2) January 27, 2017 - June 7, 2018

Allegations: the Company was experiencing cost inflation across many of the commodities and services it bought; the Company was experiencing difficulty obtaining the chassis necessary for production; the Company’s margins were being negatively impacted by a lower sales of high margin products; the Company did not have “strong visibility into future net sales” to “effectively plan” and manage its backlog of vehicles; the Company’s manufacturing operations were not operating efficiently or at a low cost to satisfy customer demand; and as a result of the foregoing, Defendants’ statements about REV’s business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis. Get additional information: http://www.kleinstocklaw.com/pslra-c/rev-group-inc?wire=3 .

PG&E Corporation (NYSE: PCG) Lead Plaintiff Deadline: August 13, 2018 Class Period: April 29, 2015 - June 8, 2018

Allegations: PG&E had failed to maintain electricity transmission and distribution networks in compliance with safety requirements and regulations promulgated under state law; consequently, PG&E was in violation of state law regulation; PG&E’s electricity networks would cause numerous wildfires in California; and as a result of the foregoing, Defendants’ statements about the Company’s business and operations were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/pge-corporation?wire=3 .

Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Joseph Klein, Esq. Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 jk@kleinstocklaw.com Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Experience Culinary Excellence at Hong Kong Wine & Dine Festival

Updated Category News Views 226

Hong Kong Wine & Dine Festival Returns This October HONG KONG, an anticipated gastronomic spectacle is set for the latter part of October. The Hong Kong Wine & Dine Festival will take place from 23 to 26 October 2025 at the iconic Central Harbourfront. This annual celebration is designed to showcase the best in culinary arts and exquisite wines, offering something special...

Continue Reading
Danaher Announces Upcoming Earnings Conference Details

Updated Category News Views 44

Danaher Sets Date for Q3 2024 Earnings Conference Call Danaher Corporation (NYSE: DHR) has announced the date for its highly anticipated quarterly earnings conference call. This event is significant for investors and stakeholders who keep a close eye on the company's developments. Earnings Call Details The earnings call is set for an upcoming Tuesday morning, during which...

Continue Reading
UniQure's Stock Climbs to Record Levels, Eyes Future Growth

Updated Category News Views 67

UniQure Stock Reaches New Heights UniQure NV (QURE) has exciting news as its stock recently touched an impressive 52-week high of $18.5. This remarkable milestone is a testament to the company's resilient growth strategy and innovative advancements in the biotechnology industry. With a market capitalization reaching $885 million, the stock has seen an astonishing rise of...

Continue Reading
MedCana's Colombian Subsidiary Partners with Australian Firm

Updated Category News Views 34

MedCana Enters Negotiations for Cannabis Supply Agreement MedCana, a prominent player in the pharmaceutical-grade cannabis landscape, is making headlines with an exciting new development from its subsidiary in Colombia. The company is set to negotiate a substantial supply agreement worth between $1.2 million and $2.4 million annually. This agreement marks a significant...

Continue Reading
Mouawad and OCTA Properties Launch Luxurious Residences

Updated Category News Views 144

Mouawad Teams Up with OCTA Properties for Luxe Residences OCTA Properties has been selected as the global licensee for residences branded by Mouawad, bringing the brand's legacy of timeless elegance into the realm of premium real estate. This partnership marks an exciting new chapter in Mouawad's prestigious journey in luxury development. A Landmark Collaboration Mouawad,...

Continue Reading